PainReform (PRFX)

• Market cap: $3.8M
• 1 day: -5.79%
• 5 days: 4.9%
• 1 month: 0.13%
• 3 months: -31.66%
• 6 months: -50.74%
• Year to date: -70.05%
• 1 year: -66.77%
• 5 years: -99.91%
• 10 years: -99.94%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Employees: 6